← Syndax Pharmaceuticals Inc

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income From Continuing Operations — — — — — — ($149.3m) ($209.4m) ($318.8m) ($285.4m)
Net Income (Loss) Attributable to Parent ($44.5m) ($60.8m) ($74.0m) ($56.0m) ($73.2m) $24.9m ($149.3m) ($209.4m) ($318.8m) ($285.4m)
Net Income (Loss) Available to Common Stockholders, Basic ($47.1m) ($60.8m) ($74.0m) ($56.0m) ($77.1m) $24.9m ($149.3m) ($209.4m) ($318.8m) ($285.4m)
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest — — ($74.0m) ($56.0m) ($73.2m) $24.9m ($149.3m) ($209.4m) ($318.8m) ($285.4m)
Depreciation $89k $76k $78k $92k $89k $43k $33.0m $12.0m $8.0m $6.0m
Amortization of Debt Issuance Costs — — — — — — $0 $0 $30k $228k
Amortization Of Securities — — — — — — ($3.4m) ($14.8m) ($13.5m) ($10.8m)
Depreciation Amortization Depletion — — — — — — $33k $12k $8k $6k
Share-based Payment Arrangement, Noncash Expense $4.7m $5.5m $6.2m $6.0m $9.1m $13.3m $16.0m $31.0m $43.0m $47.5m
Share-based Payment Arrangement, Expense $4.7m $5.5m $6.2m $6.0m $9.1m $13.3m $16.0m $31.0m $43.0m $47.5m
Income Tax Expense (Benefit) $0 $0 $0 $0 $0 $0 — — — $433k
Interest Expense Nonoperating — — — — — — — — $4.9m $6k
Operating Lease, Expense — — — $447k $425k $413k $440k $743k $1.1m $900k
Other Nonoperating Income (Expense) $41k ($269k) ($27k) ($79k) ($219k) $202k ($316k) ($361k) ($247k) ($1.3m)
Changes in operating assets and liabilities:
Additional Financial Items
Increase (Decrease) in Accounts Receivable — — — — — — — — $7.6m $30.4m
Increase (Decrease) in Inventories — — — — — — — — $366k $32.1m
Increase (Decrease) in Accounts Payable $923k ($194k) ($792k) $4.7m ($2.7m) $2.2m ($1.3m) $5.6m $1.7m $5.0m
Proceeds from Stock Options Exercised $2.1m $277k $26k $178k $6.6m $6.3m $11.5m $5.1m $8.0m $12.1m
Debt Securities, Available-for-sale, Realized Gain (Loss) — — $0 $0 $0 $0 $0 $0 $0 $0
General and Administrative Expense $13.3m $15.9m $17.3m $16.1m $22.5m $25.2m $33.3m — — —
Investment Income, Interest — — — — $841k $403k $5.9m $21.2m $26.1m $22.7m
Marketable Securities, Unrealized Gain (Loss) $28k — — — — — — — — —
Nonoperating Income (Expense) ($706k) $1.2m $1.9m $1.5m ($1.7m) ($1.3m) $2.4m $20.6m $20.9m ($12.3m)
Operating Expenses $45.0m $64.1m $77.4m $59.1m $72.9m $113.5m $151.8m $230.0m $363.4m $445.4m
Beginning Cash Position — — — — — — $222.1m $74.5m $295.6m $154.3m
Cash Flow From Continuing Financing Activities — — — — — — $172.3m $264.1m $353.4m $13.7m
Cash Flow From Continuing Investing Activities — — — — — — ($186.2m) $117.6m ($219.8m) $290.0m
Change In Account Payable — — — — — — ($1.3m) $5.6m $1.7m $5.0m
Change In Accrued Expense — — — — — — $9.4m $14.9m $19.1m $42.2m
Change In Inventory — — — — — — $0 $0 ($366k) ($32.1m)
Change In Other Current Assets — — — — — — $0 $0 $463k $0
Change In Other Working Capital — — — — — ($13.1m) ($3.5m) $10.7m $12.0m —
Change In Payable — — — — — — ($1.3m) $5.6m $1.7m $5.0m
Change In Payables And Accrued Expense — — — — — — $8.1m $20.5m $20.8m $47.1m
Change In Prepaid Assets — — — — — — ($3.0m) $676k ($8.4m) ($14.5m)
Change In Receivables — — — — — — $0 $10.7m $762k ($79.8m)
Change In Working Capital — — — — — — $1.7m $31.9m $13.3m ($79.3m)
Changes In Account Receivables — — — — — — $0 $0 ($7.6m) ($30.4m)
Changes In Cash — — — — — — ($147.6m) $221.1m ($141.3m) ($19.3m)
End Cash Position — — — — — — $74.5m $295.6m $154.3m $135.0m
Financing Cash Flow — — — — — — $172.3m $264.1m $353.4m $13.7m
Free Cash Flow — — — — — — ($133.7m) ($160.6m) ($274.9m) ($323.2m)
Gain Loss On Investment Securities — — — — — ($389k) ($187k) — — —
Investing Cash Flow — — — — — — ($186.2m) $117.6m ($219.8m) $290.0m
Issuance Of Capital Stock — — — — — — $181.4m $258.1m $0 $0
Net PPE Purchase And Sale — — — — — — $225k $0 $0 ($187k)
Operating Gains Losses — — — — — ($389k) ($187k) — — —
Other Non Cash Items — — — — — — $1.5m $739k $1.0m $1.3m
Proceeds From Stock Option Exercised — — — — — — $11.9m $6.0m $9.7m $13.7m
Provisionand Write Offof Assets — — — — — — — $0 $0 $3.7m
Purchase Of PPE $261k $84k $187k $187k $187k $129k $0 $0 $0 ($187k)
Sale Of PPE — — — — — $0 $225k $0 $0 —
Stock Based Compensation — — — — — — $16.0m $31.0m $43.0m $47.5m
Derivative, Gain (Loss) on Derivative, Net — — — — — $389k $187k $0 $0 —
Net Cash Provided by (Used in) Operating Activities ($35.2m) ($47.4m) ($68.5m) ($50.6m) ($71.3m) $29.1m ($133.7m) ($160.6m) ($274.9m) ($323.0m)
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $261k $84k $187k — $0 $129k $0 $0 $0 $187k
Net Investment Purchase And Sale — — — — — — ($186.4m) $117.6m ($219.8m) $290.2m
Purchase Of Investment — — — — — — ($495.3m) ($354.6m) ($557.1m) ($195.8m)
Sale Of Investment — — — — — — $308.9m $472.2m $337.3m $486.0m
Net Cash Provided by (Used in) Investing Activities ($18.4m) ($17.0m) $51.4m $12.8m ($142.5m) ($40.9m) ($186.2m) $117.6m ($219.8m) $290.0m
Cash flows from financing activities:
Issuance Of Debt — — — — — $0 $0 — — —
Long Term Debt Issuance — — — — — $0 $0 — — —
Net Issuance Payments Of Debt — — — — — $0 ($21.0m) $0 $0 —
Net Long Term Debt Issuance — — — — — $0 ($21.0m) $0 $0 —
Long Term Debt Payments — — — — — $0 ($21.0m) $0 $0 —
Repayment Of Debt — — — — — $0 ($21.0m) $0 $0 —
Common Stock Issuance — — — — — — $181.4m $258.1m $0 $0
Net Common Stock Issuance — — — — — — $181.4m $258.1m $0 $0
Proceeds from (Payments for) Other Financing Activities ($4k) — $8k — $1k — — — — —
Net Other Financing Charges — — — — — $576k — — $343.7m —
Net Cash Provided by (Used in) Financing Activities $54.2m $75.7m $15.7m $28.6m $304.4m $118.5m $172.3m $264.1m $353.4m $13.7m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $762k $11.3m ($1.4m) ($9.3m) $90.6m $106.7m ($147.6m) $221.1m ($141.3m) ($19.3m)
Supplemental disclosure of cash flow information:
Change In Cash Supplemental As Reported — — — — — — ($147.6m) $221.1m ($141.3m) ($19.3m)
Interest Paid, Excluding Capitalized Interest, Operating Activities — — — — $1.6m $2.0m $2.1m $0 $0 $13.2m
Income Taxes Paid, Net — — — — — — — — — $150

Data sourced from SEC EDGAR 10-K filings via EdgarTools. Amounts are shown in USD as reported in each fiscal year filing.